Delivery Order SPE2DB20D2104-SPE2DB25FMMAB

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,375.98, is a delivery order for JANUMET XR 100-1,000 MG TABLET 90S. The contract is a firm fixed-price arrangement with a completion date of February 23, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,119.69 delivery order contract is for the supply of JANUMET XR 100-1,000 MG TABLET 90S, a prescription medication. The contract has a completion date of July 3, 2025 and is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,490.05 firm fixed-price delivery order contract is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has an ultimate completion date of July 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,607.94, is a delivery order for JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has an ultimate completion date of November 30, 2023 and is a firm fixed-price delivery order. The award was not designated with a set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of JANUMET XR 100-1,000 mg tablets. The firm-fixed-price contract has a ceiling value of $5,883.42 and an ultimate completion date of April 18, 2024. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, leverages its extensive supply chain to fulfill government contracts, particularly for the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of JANUMET XR 100-1,000 mg tablets. The $2,172.96 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 25, 2024. The contract is not designated with a set-aside, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The $2,665.85 firm fixed price delivery order is for the pharmaceutical product JANUMET XR 50-1,000 MG TABLET 180S. The contract has an ultimate completion date of June 13, 2025 and is not set aside. Amerisourcebergen Drug Corp is the prime contractor and holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,766.65 firm fixed-price delivery order is for the supply of JANUMET XR 50-1,000 mg tablets. The award has an ultimate completion date of August 30, 2024 and was issued on August 29, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $5,796.55 for 4557782727 JANUMET XR 50-1,000 MG TABLET 180S. The award was made by the Defense Logistics Agency (DLA), a defense agency, on July 13, 2022 with a completion date of July 14, 2022. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,064.96 firm-fixed-price delivery order is for the supply of JANUMET XR 50-500 MG TABLET 180S, a pharmaceutical product. The contract has an ultimate completion date of June 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMMAB
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp is a delivery order with a firm fixed price of $1,232.36 for the supply of JANUMET XR 100-1,000 MG TABLET 90S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 28, 2025. The contract is not designated as a set-aside.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/26/25, 10:10 AM